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It is a widely held belief that the arterial pole of the zebrafish heart is unusual among models of comparative cardiogenesis. This is based, in
part, on the report that the bulbus arteriosus undergoes a striated-to-smooth muscle phenotypic transition during development. An implication of
this is that the zebrafish, a model almost ubiquitously accepted in other fields of comparative biology, may be poorly suited to the study of
conotruncal abnormalities in human disease. However, while the use of atrioventricular-specific molecular markers has allowed extensive
characterization of the development of the atrium and ventricle, the lack of any bulbus-specific markers has meant that this region of the zebrafish
heart is poorly characterized and quite possibly misunderstood. We have discovered that the fluorescent nitric oxide indicator 4,5-
diaminofluorescein diacetate (DAF-2DA) specifically labels the bulbus arteriosus throughout development from approximately 48 h post-
fertilization. Therefore, using DAF-2DA and an immunohistochemical approach, we attempted to further characterize the development of the
bulbus. We have concluded that no such phenotypic transition occurs, that contrary to current thinking, aspects of zebrafish arterial pole
development are evolutionarily conserved, and that the bulbus should not be considered a chamber, being more akin to the arterial trunk(s) of
higher vertebrates.
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Over two decades of extensive zebrafish research has
validated its utility as a comparative biological model, and
because of its rapid development and genetic tractability, Danio
rerio has come to exemplify and legitimize the use of fish to
model human disease (Epstein and Epstein, 2005). In
particular, the species offers many advantages to the study of
comparative cardiac morphogenesis and although there are
fundamental differences between fully developed zebrafish and
human hearts, at the heart-tube stage of development, they are
morphologically almost indistinguishable (Fishman and Chien,
1997). It is widely reported that the teleost heart is comprised
of four chambers, with blood flowing posterior to anterior
through the sinus venosus, atrium, ventricle and bulbus0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2005.11.042
* Corresponding author. Duke University Medical Center, Department of
Pediatrics (Neonatology), Bell Research Building, Trent Drive, Durham, NC
27710, USA. Fax: +1 919 668 1599.
E-mail address: grimes@duke.edu (A.C. Grimes).arteriosus (Goodrich, 1930; Stainier et al., 1993; Bone et al.,
1999; Hu et al., 2000, 2001; Simo˜es et al., 2002). However,
while there may be an implicit understanding that only the
atrium and ventricle are Ftrue_ cardiac chambers (e.g. Orr,
1982), confusion in the literature is such that the teleost heart
has also been described variously as having two chambers (e.g.
Schmidt-Nielsen, 1997) or three (Young, 1981), with the sinus
venosus and bulbus arteriosus being occasionally described as
Fsubsidiary chambers_ (e.g. Hickman et al., 1988) lacking in
the mammalian heart (McCauley, 1971). It has therefore
remained unclear how the bulbus should be designated, and
this is by no means a trivial matter, as it is difficult to imagine
how the four-chambered heart and parallel circulations of birds
and mammals could have evolved from a three- or four-
chambered, serial-circulation precursor. Although the adult
bulbus lacks cardiac muscle and has characteristics that suggest
it may originate from the ventral aorta (Lawson, 1979), an
alternative theory is that it is of cardiac origin and may be an
extension of the anterior portion of the heart, which subse-
quently loses its myocardial phenotype (Hu et al., 2000; Hu et90 (2006) 265 – 276
www.e
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disproportionate amount of zebrafish cardiac research has been
concentrated on the atrium and ventricle at stages long before
the bulbus is formed.
Fate-mapping experiments have facilitated the identification
of atrioventricular progenitors in the lateral marginal zone of
the early embryo prior to gastrulation (Keegan et al., 2004;
Stainier et al., 1993). Furthermore, the use of atrial- and
ventricular-specific molecular markers such as ventricular
myosin light chain (vmlc) and cardiac myosin light chain
(cmlc) has demonstrated that these two chambers are formed
from distinct, but overlapping populations of cells (Keegan et
al., 2004). These cardiac progenitors have been followed as
they ingress through gastrulation and migrate with the lateral
plate mesoderm towards the cranial midline, where they
approach each other and fuse to form the primitive, beating
heart tube by 24 h post-fertilization (hpf) (Stainier et al., 1993).
The atrium and ventricle are both recognizable distinct
structures within just 36 hpf.
In contrast, the bulbus arteriosus appears to be added to the
heart after 48 hpf, at a stage when the atrium and ventricle are
already formed and pumping blood through a rudimentary
circulatory system. Because it forms so late, it is usually
excluded from studies of the Ftrue_ cardiac chambers, and a
detailed analysis of its development has not been undertaken.
Thus, as with other models used in the study of cardiogenesis
(e.g. chick and mouse), confusion surrounds zebrafish arterial
pole development.
One aspect that has seemed particularly enigmatic, and
which both perpetuates the aforementioned confusion while
also making the zebrafish unique among models of cardio-
genesis, is the oft-cited report that the bulbus undergoes a
transformation from a myocardial-covered heart chamber to a
smooth muscle-covered arterial trunk during development (Hu
et al., 2000). This observation has led to speculation about the
processes involved (e.g. Rothenberg et al., 2003) and whether
transdifferentiation, as proposed in other models such as chick
and rat (Argue¨llo et al., 1978; Ya et al., 1998), or remodeling
through apoptosis, as shown in chick (Watanabe et al., 1998), is
responsible for this change. However, the initial report was
based on interpretation of histological data using a marker for
striated muscle (myofilament-20, MF-20 Bader et al., 1982),
but no marker for smooth muscle, and the timing of that
transition was not documented sequentially.
We have discovered that the fluorescent nitric oxide (NO)
indicator 4,5-diaminofluorescein diacetate (DAF-2DA) specif-
ically labels the bulbus arteriosus from approximately 48 hpf
and remains specific to the bulbus throughout development.
Therefore, using DAF-2DA and multiple immunohistochemi-
cal markers for a basement membrane protein and both striated
and smooth muscle, we attempted to better characterize the
reported phenotypic change in both whole-mount and sec-
tioned zebrafish embryos and discovered that the original
report of a myocardial-to-smooth muscle transition was likely
based on the misinterpretation of histological data. Here, we
show that the bulbus arteriosus is never striated and that no
phenotypic transition occurs. Furthermore, we demonstrate thataspects of zebrafish arterial pole development are evolution-
arily conserved and that the bulbus should not be considered a




Zebrafish were maintained following protocols described by Westerfield
(1993) and Nusslein-Volhard and Dahm (2002). Eggs were generated from
natural spawnings of AB or Tu¨bingen wild-type (wt) fish, cleaned in fish water
(300 Ag/ml Instant Ocean Sea Salt in distilled water) and then maintained in
blue water (fish water with 1 ng/ml methylene blue) at 28.5-C using standard
protocols. In one experiment, embryos were generated by crossing wt fish with
cmlc::DsRed2-nuc transgenics (Mably et al., 2003; a kind gift from Dr.
Kenneth Poss [Duke University] with permission from Dr. Geoffrey Burns
[Harvard Medical School]). Healthy embryos at various stages of development
from 24 hpf to 30 days post-fertilization (dpf) (staged according to Kimmel et
al., 1995) were selected for the experiments, transferred to a 35 mm petri dish
and, when necessary, their chorions removed manually using watchmaker
forceps. Thirteen adult fish (over 9 months old) were used for double-label
immunohistochemistry experiments.
DAF-2DA labeling
Live embryos were transferred from blue water directly into a 10 AM
solution of DAF-2DA (Calbiochem, San Diego, CA) in fish water adjusted to
pH 7.0 and incubated for 4 h in the dark at 28.5-C. Following incubation,
embryos were either visualized in vivo or fixed in preparation for further
immunohistochemical labeling as below. DAF-2DA is a membrane-permeable
compound developed to detect the presence of NO in vivo (Kojima et al.,
1998). After readily entering cells, DAF-2DA is hydrolyzed by endogenous
esterases and converted to the membrane-impermeable 4,5-diaminofluorescein
(DAF-2). This in turn reacts with NO in the presence of oxygen to yield the
highly fluorescent adduct triazolofluorescein (DAF-2T), with fluorescence
being linearly correlated (up to saturation levels) with the concentration of the
compound.
Immunohistochemistry
Initial double-labeling experiments were performed without the use of
DAF-2DA. Embryos were anaesthetized in 0.016% tricaine and fixed for 50
min using 2% paraformaldehyde in PBS (pH 7.4). Following fixation, embryos
were rinsed in PBS, placed in blocking solution (PBS with 10% [v/v] sheep
serum; 2 mg/ml BSA; 0.2% [w/v] saponin) for 50 min and then incubated in
1:20 monoclonal antibody MF-20 supernatant (Developmental Studies
Hybridoma Bank, University of Iowa, IA) in antibody buffer (PBS with
0.2% saponin; 2% milk) for 2 h at room temperature. After rinsing in PBS,
embryos were incubated for 2 h at room temperature in the dark with 1:500
AlexaFluor 568 goat anti-mouse IgG2b secondary antibody (Molecular Probes,
Eugene, OR) in antibody buffer as before. After a further rinse in PBS, embryos
were incubated overnight at 4-C in the dark with 1:1000 anti-smooth muscle a-
actin monoclonal antibody conjugated to FITC (Sigma) in antibody buffer. This
protocol allowed visualization of striated muscle in red and smooth muscle in
green. Prior to whole-mount visualization, embryos were dehydrated in
methanol series and cleared in 2:1 benzyl benzoate:benzyl alcohol.
Four adult fish were fixed overnight at 4-C in 4% paraformaldehyde, their
hearts exposed by opening the pericardial cavity and double-labeled as above.
Following labeling, the hearts were excised from the fish and imaged.
For DAF-2DA experiments, after incubation in a solution of the reagent as
above, embryos were rinsed in fish water, anesthetized in 0.016% tricaine and
fixed for 30 min using 2% paraformaldehyde in PBS (pH 7.4). Following
fixation, embryos were rinsed in PBS, placed in blocking solution as above for
50 min and then incubated in antibody buffer for 2 h at room temperature with
primary antibodies as follows. Either 1:20 monoclonal antibody MF-20
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(Developmental Studies Hybridoma Bank, University of Iowa, IA); or 1:1 anti-
sarcomeric myosin monoclonal antibody NA-4 supernatant (Developmental
Studies Hybridoma Bank, University of Iowa, IA); or 1:1000 anti-smooth
muscle MLCK monoclonal antibody, clone K36 (Sigma); or 1:100 anti-smooth
muscle MHC IgG (Biomedical Technologies, Stoughton, MA); or 1:1000 anti-
smooth muscle a-actin, clone 1A4 (Sigma). After rinsing again in PBS,
embryos were incubated for 2 h at room temperature in the dark with either
1:500 AlexaFluor 568 goat anti-mouse IgG (H + L) or 1:500 AlexaFluor 568
goat anti-rabbit IgG (H + L) secondary antibodies (Molecular Probes, Eugene,
OR) in antibody buffer as before. Prior to visualization, embryos were
dehydrated in methanol series and cleared in 2:1 benzyl benzoate:benzyl
alcohol. This protocol allowed for visualization of either striated or smooth
muscle structures in red and DAF-2DA reactivity in green.
Frozen sections
After labeling with anti-striated muscle/anti-smooth muscle antibodies,
embryos at various developmental stages were rinsed in PBS, transferred to 5%
(w/v) sucrose/PBS at 4-C for 4 h and then left at 4-C overnight in 20% (w/v)
sucrose/PBS. Embryos were infiltrated with 7.5% (w/v) gelatin (Sigma G2500)/
15% (w/v) sucrose/PBS at 38-C for 4 h and then embedded in disposable
moulds by cooling the same mixture to room temperature. Moulds were
discarded, and the congealed gelatin/sucrose was trimmed and mounted on a
cryostat chuck with OCT compound and frozen for 1 min in dry-ice-chilled
isobutane. Embryos were sectioned at 12 Am on a Leica CM3050S cryostat,
mounted on glass slides and allowed to dry at room temperature. Slides were
soaked in PBS for 30 min at 38-C to clear the gelatin and then coverslipped
using warmed ProLong Gold Antifade Reagent with DAPI (Molecular Probes,
Eugene, OR) to allow visualization of cell nuclei.
Paraffin embedding and sectioning
Following whole-mount visualization of DAF-2DA and anti-striated
muscle/anti-smooth muscle reactivity, selected embryos were transferred
directly from 2:1 benzyl benzoate:benzyl alcohol to xylenes and allowed to
equilibrate for 5 min prior to being placed in paraffin at 60-C. Embryos were
embedded in disposable plastic moulds and allowed to cool before being
sectioned at 8 Am on a Leica RM2155 microtome, mounted on glass sides and
allowed to dry overnight in the dark. The following day, slides were heated to
60-C in an oven, placed in xylenes for 5 min, rehydrated through ethanol series
to water and coverslipped using warmed ProLong Gold Antifade Reagent with
DAPI.
Additional histology and immunohistochemistry
Nine adult fish, three of which had been incubated overnight in a solution
of DAF-2DA, were fixed overnight at 4-C in 4% paraformaldehyde, their
hearts excised and prepared for paraffin embedding and sectioning as above.
One subset of sections was stained with hematoxylin, eosin and Mallory’sFig. 1. Confirmation of smooth muscle phenotype in the adult zebrafish bulbus arte
smooth muscle alpha-actin (green); lateral view, dorsal to the top, cranial to the rigtrichrome stain using standard histochemistry protocols, and coverslipped using
Cytoseal-60 (Richard Allan Scientific, Kalamazoo, MI). A second subset was
double-labeled with MF-20 and polyclonal anti-laminin antibody (L9393,
Sigma) after being predigested with 0.5% papain (Sigma) in 0.02 M phosphate
buffer (pH 4.7) for 10 min at 37-C, rinsed in Tris/Tween (0.1 M Tris [pH 7.6]/
0.1% Tween 20) and pre-blocked using Tris/Tween/2% FBS. Sections were
serially incubated for 1 h each with 1:20 MF-20, 1:200 AlexaFluor 568 goat
anti-mouse IgG (H + L) secondary antibody, 1:1000 L9393 anti-laminin and
1:200 AlexaFluor 488 goat anti-rabbit IgG (H + L) secondary antibody.
Between each incubation, slides were rinsed in Tris/Tween and blocked in Tris/
Tween/FBS. The remainder of the sections (those showing DAF-2DA
reactivity) was labeled with 1:20 MF-20 using similar protocols as above.
Following staining, sections were rinsed in water and coverslipped using
warmed ProLong Gold Antifade Reagent with DAPI.
DAF-2DA reactivity in chick
Fertilized chicken eggs, obtained from the Gold Kist Hatchery, Siler City,
NC, were incubated at 37-C and 70% humidity in a forced-draft incubator.
Embryos were revealed by cutting a small (1W  1/2W) opening in the egg.
Approximately, 2 Al of a 5 mM DAF-2DA solution was injected into a vitelline
vein of embryos at HH stages 24–34 (Hamburger and Hamilton, 1951) using
back-filled pulled glass capillaries. The eggs were sealed using Scotch-tape and
then incubated for an additional 24 h before the hearts were dissected, fixed
overnight in 4% paraformaldehyde, labeled with MF-20 using similar protocols
as above and then placed in PBS for visualization.
Imaging
Whole-mount embryos were visualized using a Leica MZ FLIII microscope
equipped with a Q-Imaging Retiga 1300i camera and EXFO X-cite 120
Fluorescence Imaging System. Paraffin and frozen sectioned embryos were
visualized using a Leica DM RAZ microscope equipped similarly with camera
and fluorescence imaging system. Overlay images were generated using
Improvision Openlab software or Adobe Photoshop.
Results
The zebrafish bulbus arteriosus is never striated
Histological analysis has revealed that the adult zebrafish
bulbus contains a considerable volume of smooth muscle (Hu
et al., 2001), and we confirmed this by anti-smooth muscle
actin labeling of several adult hearts (Fig. 1). However,
although in early-stage embryos we found that both skeletal
muscle and myocardium were clearly marked by MF-20 from
24 hpf, none of the smooth muscle markers labeled any cardiac
region during stages of development when the bulbus wasriosus. Whole-mount immunolabeling using anti-myosin MF-20 (red) and anti-
ht. a—atrium. ba—bulbus arteriosus. v—ventricle. Scale bar—500 Am.
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reactivity was seen in the bulbus at various late stages, but only
after it was already formed, and the timing of that reactivity
depended on the marker being used. In our experiments, anti-
smooth muscle myosin light chain kinase (sMLCK) was the
earliest marker to label smooth muscle in the bulbus and was
identifiable after approximately 20 dpf (data not shown).
However, although we were unable to show the presence of
smooth muscle in the early developing bulbus using immuno-
histochemistry, we also discovered in all embryos examined
(from 24 hpf through to over 30 dpf) that neither was there any
evidence of striated muscle in this structure at any stage of
development, as MF-20 labeling did not extend beyond the lip
of the ventricle. Fig. 2A shows that, at 36 hpf, striated muscle is
limited to the atrium and ventricle, and frozen sagittal sections
of immunolabeled embryos at various developmental stagesFig. 2. The zebrafish bulbus arteriosus is non-striated throughout development
developmental stages. B–D are frozen sections, labeled with MF-20 (red), anti-smo
sections, labeled with anti-tropomyosin (red) and DAPI (blue). In A, the head is to th
and anterior to the right. A: 36 hpf. MF-20 (red) shows that striated myocardium do
valve will eventually form. Note that the bulbus is not an obvious structure at this
development, the smooth muscle marker does not label the bulbus (blood cells au
striated muscle in the bulbus using MF-20. E: 6 dpf. F: 12 dpf. Anti-tropomyosi
processing for paraffin embedding has eliminated blood cell autofluorescence). Not
derived from skeletal muscle. a—atrium. avc—atrioventricular canal. ba—bulbus aalso illustrate that the bulbus is never striated (Figs. 2B–D).
This lack of myocardium in the bulbus arteriosus was
confirmed by the use of two additional striated muscle markers,
CH-1 against tropomyosin (Figs. 2E, F) and NA-4 against
sarcomeric myosin (data not shown). However, because a
phenotypic transition had been previously reported (Hu et al.,
2000) and the bulbus described as a ring of MF-20-positive
cardiomyocytes distal to the ventricle in transverse-sectioned
early embryos, we attempted to duplicate that data and
discovered that this ring was in fact a narrow band of striated
myocardium at the lip of the ventricle in a region of the heart
surrounding and supporting the bulboventricular valve. For
example, in a 5 dpf embryo, MF-20 reactivity did not extend
further than approximately 16 Am (2  8 Am sections) distal to
the valve (Fig. 3), and this region does not correspond to the
wall of the bulbus.. Immunolabeled whole-mount (A) and sagittal sections (B–F) of various
oth muscle alpha actin (green) and DAPI (blue). E and F are paraffin-embedded
e top of the image, dorsal to the right. In B–F, dorsal is to the top of the image
es not extend beyond the outflow portion of the ventricle, the region where the
early stage of development. B: 5 dpf. C: 8 dpf. D: 13 dpf. At these stages of
tofluoresce in the green spectrum). However, neither is there any evidence of
n confirms the lack of striated myocardium in the bulbus (in these sections,
e that the MF-20 and anti-tropomyosin signal adjacent to the bulbus in C–F is
rteriosus. sk—skeletal muscle. v—ventricle. Scale bars—100 Am.
Fig. 3. Striated myocardium does not extend beyond the lip of the ventricle. Serial (anterior to posterior) 8 Am transverse sections through the bulbus arteriosus and
ventricle of a 5 dpf embryo. MF-20 (red), DAPI (blue). These images show that there is a narrow band of striated myocardium just distal to the bulboventricular
valve (two cusps are seen clearly in F). However, this does not extend into the bulbus. A–C: anterior sections of the bulbus negative for MF-20. Skeletal muscle
shows positive labeling. D–F: the striated ring of the Fventricle lip_ becomes apparent close to the valve. G– I: sections immediately posterior to the valve
show MF-20-positive labeling in the ventricle. ba—bulbus arteriosus. bv—bulboventricular valve. lv—lip of ventricle. sk—skeletal muscle. v—ventricle. Scale
bar—100 Am.
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The lack of an effective molecular marker for the zebrafish
arterial pole would have made any attempt to characterize its
development problematic. However, we have discovered the
first bulbus-specific marker, DAF-2DA, and found that it
marks the bulbus arteriosus at stages of development when the
heart is still undergoing considerable developmental and
morphological change. After incubation in a solution of
DAF-2DA, fluorescence was observed in the outflow portion
of the heart of live fish (Fig. 4A). Although some fluorescence
could also be seen in other regions of the embryo, such as the
gut and pronephros, strong DAF-2DA reactivity was not
observed in any other region of the cardiovascular system.
After observation of whole-mount embryos, some were
selected for fixation, paraffin embedding and sectioning. Both
DAF-2DA- and striated muscle-derived fluorescence was still
robust after these procedures. DAF-2DA reactivity in thebulbus was distinct from labeling in the ventricle and atrium
(Fig. 4B), and dissected hearts showed clear marker-derived
delineation between the ventricle and bulbus (Fig. 4C). In
section, DAF-2DA reactivity was observed along the entire
length of the bulbus from the outflow portion of the ventricle to
the ventral aorta and was confirmed as being distinct from
striated muscle labeling in the ventricle (Figs. 4D–I). The
localized reactivity of this marker was further confirmation that
the bulbus is phenotypically distinct from the atrioventricular
regions of the heart.
DAF-2DA labeling of the bulbus was first observed in
embryos that had reached approximately 48 hpf, when the
outflow portion of the heart is little more than a narrow
band of striated myocardium surrounding the lip of the
ventricle. Blood passing through this rudimentary vessel can
be seen entering the branched arteries leading to what will
become the gill arches later in development. The bulbus
remained DAF-2DA reactive throughout development and
Fig. 4. DAF-2DA and MF-20 label distinct regions of the zebrafish heart. A–C: double-labeled, 5 dpf zebrafish. Scale bars—250 Am. A: ventral view, head is to the
top–right. In vivo DAF-2DA labeling. The fluorescent bulbus can be seen in the center of the image (circled), the yolk is also autofluorescing (bottom– left of
image). B: similar ventral view to that seen in A, head is to the top–right. DAF-2DA (green) and MF-20 (red) overlay. MF-20 reactivity can be seen in the striated
skeletal muscle and in the cardiac muscle of the ventricle. C: lateral view, dorsal to the top, anterior to the right. DAF-2DA and MF-20 overlay of dissected heart
shows the clear delineation between bulbal and striated markers. D–I: transverse 8 Am serial sections—anterior to posterior. DAF-2DA, MF-20 and DAPI (blue)
staining in 5 dpf zebrafish. Scale bar—100 Am. D: DAF-2DA labeling becomes evident at the tip of the bulbus, close to the ventral aorta. E–G: the bulbus increases
in diameter anterior to posterior. H: the DAF-2DA labeled bulbus abuts the MF-20-positive ventricle with no evidence of colocalization in any cells. I: only MF-20-
positive myocardium is evident in the ventricle. aa—arch artery. ba—bulbus arteriosus. lv—lip of ventricle. sk—skeletal muscle. v—ventricle.
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such as sMLCK, became evident and colocalized with the
DAF-2DA domain (Fig. 5), suggesting that it is an early
marker of smooth muscle phenotype. In addition, although
21 dpf embryos showed evidence of DAF-2DA reactivity in
large blood vessels such as the arch arteries (data not
shown), this fluorescence was distinct from that seen in the
bulbus and not nearly as intense. It should be noted that
another nitric oxide indicator, the red fluorescent diaminor-
hodamine 4M (DAR-4M AM), also marks the bulbus
arteriosus (data not shown).
The bulbus does not express cardiac myosin light chain-2
Because our panel of striated muscle markers also labels
skeletal muscle and can cause confusing background signal, we
confirmed the absence of a cardiac-specific gene in the bulbusby using cmlc2::DsRed2-nuc transgenic fish in which red
fluorescent protein (RFP) is expressed under the cardiac
myosin light chain-2 promoter (Mably et al., 2003). In these
fish, RFP expression was restricted to the atrium and ventricle
and was not expressed in the bulbus at any stage of
development (Fig. 6), further demonstrating an obvious
delineation between the bulbus arteriosus and the atrioventric-
ular portion of the heart.
DAF-2DA also marks the arterial pole of the chick heart
To ascertain the evolutionary significance of our observa-
tions of nitric oxide release in the bulbus, we investigated
DAF-2DA reactivity in chick. Fluorescence was observed in
the arterial pole of the chick heart after HH stage 23 in a region
of nascent smooth muscle known to be added to the base of the
common arterial trunk during HH stages 18–22 (Waldo et al.,
Fig. 5. Anti-sMLCK is the first smooth muscle marker to label the bulbus arteriosus. A–C: lateral view of 21 dpf zebrafish. Head is to the right, dorsal to the top.
Scale bar—250 Am. A: DAF-2DA shows strong reactivity in the bulbus. B: the same fish showing anti-sMLCK reactivity. C: overlay image showing colocalization
of markers. D–E: transverse section through a 21 dpf bulbus, mid-way between the ventricle and ventral aorta. D: DAF-2DA labeling is restricted to the wall of the
bulbus. E: strong sMLCK labeling (red) shows a ring of smooth muscle surrounding the inner subendothelium layer. F: overlay DAF-2DA and sMLCK (on
brightfield background) shows colocalization of markers restricted to the wall of the bulbus. Scale bars—50 Am.
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septation occurs (Figs. 7A–C) and continued until at least HH
stage 36 (Figs. 7G–I), when septation is complete and other
smooth muscle markers become effective in the chick proximal
aorta and pulmonary trunk. Immunolabeling revealed that MF-
20 and DAF-2DA are found in overlapping regions of the
arterial trunk extending to the truncal–ventricular border.
However, as can be seen in Fig. 7F, the myocardium forms a
collar around the DAF-2DA reactive cells. Transverse sections
confirmed that DAF-2DA and MF-20 label distinct concentric
layers of this region of the arterial trunk (Fig. 8). Throughout
development, the length of this overlapping region diminishes
as the myocardium compacts and regresses towards the
ventricle, and by stage 36, when outflow septation is complete,
it is limited to a very narrow band just above the semilunar
valves (Figs. 7I and 8).Fig. 6. The bulbus does not express cardiac myosin light chain-2. In vivo DAF-2DA
the top– left. Autofluorescence can be seen in the yolk (bottom– left of image) an
promoter is limited to the atrium and ventricle (circled). B: DAF-2DA reactivity in th
bulbus and other regions of the heart. Scale bar—100 Am.The bulboventricular valve is supported by a distinct region of
myocardium
Because there is an overlap of DAF-2DA and MF-20
labeling at the base of the chick arterial pole and because there
is some evidence that the conus exists in some teleosts (e.g.
Schib et al., 2002), we further investigated the junction of the
ventricle and bulbus arteriosus in adult zebrafish. Fig. 9 shows
that supporting the bulboventricular valve, there is a region of
compact, non-trabeculated myocardium that is rich in collagen
and which has a basement membrane staining strongly for
laminin. In contrast, laminin is only expressed in the outermost
edge of the remainder of the ventricle, and there is less
evidence of collagen in the trabeculae. Furthermore, similar to
the chick and particularly reminiscent of the staining pattern
observed in the chick pulmonary trunk, DAF-2DA and MF-20staining of a 5 dpf cmlc2::DsRed2-nuc transgenic fish. Ventral view, head is to
d the eye (top–center). A: red fluorescent protein expressed under the cmlc-2
e bulbus. C: overlay image showing obvious phenotypic delineation between the
Fig. 7. DAF-2DA reactivity is evolutionarily conserved. DAF-2DA (green) and MF-20 (red) labeling of chick hearts: A: HH stage 26, brightfield image. At this
stage, the arterial trunk is a non-septated tube. B: same as in A, showing MF-20 and DAF-2DA labeling. C: enlargement of truncal region in B, showing DAF-2DA
reactivity in cells of the arterial trunk beneath the myocardial layer. Some positive cells can also be seen distal to the myocardium (arrowheads). D: HH stage 29,
brightfield image. The arterial trunk is now undergoing septation. E: same heart as in D, labeled with MF-20 and DAF-2DA. F: enlargement of DAF-2DA-positive
region in E, showing strong reactivity in all regions of the aortic sac, particularly in the region of the outflow septum (arrow) and in the vessel walls. The MF-20-
labeled myocardium is undergoing compaction and regression towards the ventricle but still surrounds a region of DAF-2DA-positive cells. G: HH stage 36,
brightfield image. Septation is now complete. H: same as in G, showing MF-20 labeling and strong DAF-2DA reactivity in all regions of the arterial trunk. I:
enlargement of the DAF-2DA-positive region seen in H. There is now little overlap of the MF-20- and DAF-2DA-positive regions. at—arterial trunk. la—left atrium.
lv—left ventricle. ra—right atrium. rv—right ventricle. Scale bars—500 Am.
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dium forms a collar around the base of the bulbus and the
DAF-2DA reactivity extends down to the roots of the valve
leaflets.
Discussion
The zebrafish is an almost ubiquitously accepted model for
comparative biology and has been used extensively for the study
of early cardiogenesis. However, much of this research has been
concentrated primarily on the development of the atrium and
ventricle, at stages long before the bulbus is formed. As a result,
this structure has been poorly characterized and, as demonstrated
here, undoubtedly misunderstood. In particular, the much-cited
and unusual feature of zebrafish development, a striated-to-
smooth muscle phenotypic transition in the bulbus, implied that
the zebrafish may be poorly suited as a model of conotruncalmalformations in human disease. However, we have shown that
this enigmatic characteristic was likely based on the misinter-
pretation of histological and morphological data. This finding
has wide-reaching and profound implications, encompassing
topics as diverse as evolution, development, anatomy, physiol-
ogy and human congenital heart defects, and introduces the
potential for a paradigm shift in the field of comparative
cardiogenesis by allowing the future use of a highly desirable
and versatile model in the study of arterial pole development.
Having confirmed that the adult zebrafish bulbus is invested
with a considerable volume of smooth muscle, we attempted to
follow its development using a panel of immunohistochemical
muscle markers and discovered that the muscular phenotype of
the bulbus is difficult to characterize in the early embryo. This
is because the range of available smooth muscle markers does
not react against cells of the bulbus until stages in development
after it is already formed. Although such antibodies will mark
Fig. 8. DAF-2DA and MF-20 label distinct concentric rings in the arterial trunk. Transverse sections through the arterial pole of a stage 36 chick heart, labeled with
MF-20 (red) and DAF-2DA (green). Dorsal is to the top of images B through D. A: whole-mount image of arterial trunk showing planes of section in the following
images. B: section through the pulmonary artery and aorta above the myocardial trunk. MF-20 labels the atrium. C: plane of section just below the distal limit of
myocardium in the pulmonary trunk and aorta, showing clear separation of the concentric MF-20- and DAF-2DA-labeled layers. At this level, there is little
myocardium in the aorta compared to the pulmonary trunk (arrowheads). D: plane of section is just above the semilunar valves, the cusps of which can be seen just
behind the focal plane. Other than in a small region at the center of the aorticopulmonary septum, the pulmonary trunk is now almost completely surrounded by
myocardium (arrowheads). DAF-2DA-positive cells still connect the two arteries and partially line their walls. The wall of the ventricle can now be seen dorsal
to the pulmonary trunk and to the right of the aorta. a—atrium. ao—aorta. pa—pulmonary artery. pt—pulmonary trunk. wv—wall of the ventricle. Scale
bar—250 Am.
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development when it is being added to the heart. This is not a
complete surprise, as a similar lack of reactivity has been
observed in other models. For example, the same range of
smooth muscle markers does not label the chick proximal aorta
and pulmonary trunk until advanced stages of outflow
septation (Waldo et al., 2005a,b). While this lack of an
effective marker may have hindered our attempts to character-
ize a phenotypic change, we discovered in all embryos
examined (from 24 hpf through to over 30 dpf) that our panelFig. 9. The bulboventricular valve is supported by a distinct region of myocardium.
the images. A: hematoxylin and eosin/Mallory’s trichrome stain. The bulbus arteriosu
supporting the valve stains more strongly blue than the ventricle, particularly at th
trabeculated myocardium extends a considerable distance caudal to the valve (black a
positive tissue supporting the valve clearly includes striated muscle (white arrowhe
distinctive character in comparison to the trabeculated myocardium of the ventricl
bulbus and lumenal edge of the tissue supporting the valve, while the outer edge
(ventricular) side of the valve. ba—bulbus arteriosus. bv—bulboventricular valve.of striated muscle markers never actually marked the bulbus
either. We have therefore concluded that, although a portion of
the arterial pole of the zebrafish heart is indeed striated during
early development, this is not what will become the bulbus, a
structure that appears to be added to the heart after the atrium
and ventricle are already formed and which does not declare
itself as muscle of any variety until much later in development.
What was previously described as the Fstriated bulbus_ was
undoubtedly the very narrow band of myocardium between the
region of the bulboventricular valve and the bulbus per se.Longitudinal sections through the zebrafish arterial pole. Cranial to the right of
s is highly collagenous, indicated by the intense blue staining. The myocardium
e lumenal edge, and is both compact and non-trabeculated. Note that the non-
rrowheads). B: anti-laminin (green), MF-20 (red) and DAPI (blue). The MF-20-
ads). However, this region also stains intensely for laminin, demonstrating its
e. C: DAF-2DA (green), MF-20 (red) and DAPI (blue). DAF-2DA labels the
is MF-20-positive. However, it does not label the myocardium on the caudal
c—conotruncus? v—ventricle. Scale bar—250 Am.
A.C. Grimes et al. / Developmental Biology 290 (2006) 265–276274The study of the development of the teleost bulbus
arteriosus remains controversial. Evolutionarily, it is generally
accepted that the conus, a prominent structure found in the
elasmobranchs (sharks, skates and rays) and lined with several
rows of valves, diminished in size as the bulbus developed in
the bony fishes (Guerrero et al., 2004; Schib et al., 2002;
Farrell and Jones, 1992; Satchell, 1991). In many cases, it has
been assumed that the teleost conus remains as either a
vestigial structure or has actually disappeared completely as a
consequence of the progressive development (physical and
functional) and dramatic increase in size of the bulbus. We
have found that the region of myocardium at the lip of the
ventricle, which surrounds and supports the bulboventricular
valve, is phenotypically distinct from the myocardium in the
remainder of the ventricle, as it is more collagenous and stains
intensely for laminin (Fig. 9). This region of the zebrafish
arterial pole appears strikingly similar to the pulmonary trunk
and infundibulum of the chick, as there are concentric rings of
distinct tissue above the valve and clearly a stretch of non-
trabeculated myocardium below, suggesting that there may be a
vestigial conotruncus in the zebrafish. Thus, our work supports
the assertions of Guerrero et al. (2004) and Schib et al. (2002),
who have clearly demonstrated the presence of the conus in the
sturgeon (Acipenser naccarii) and the gilthead seabream
(Sparus auratus), respectively, and have suggested that a
review of the assumed disappearance of the teleost conus may
be necessary (Guerrero et al., 2004). However, Guerrero et al.
(2004) still propose a developmental transition from striated to
smooth muscle in the bulbus, an interpretation of data that was
likely based on the assumption that such a transition occurs in
the zebrafish. A simpler explanation of their observations is a
craniocaudal growth of the bulbus as the conus compacts or
regresses towards the ventricle over developmental time. Our
work should provide a foundation that will allow a reassess-
ment and clarification of some of these issues.
In our attempts to further an understanding of the outflow
region of the zebrafish heart, we have discovered that DAF-
2DA, a fluorescent nitric oxide indicator, specifically marks the
zebrafish bulbus arteriosus from approximately 48 hpf and to
adulthood. It is therefore effective through stages of develop-
ment during which the arterial pole of the zebrafish heart is
changing from a simple narrow band of striated muscle around
the lip of the ventricle (where the bulboventricular valve will
form) to the more easily distinguishable, elongated, bulbal
structure seen in the juvenile (and adult) fish. Furthermore, this
is a time during which the atrioventricular portion of the heart
is undergoing considerable morphological alteration. After 2
days of development, a considerable volume of yolk remains,
so the heart is curved around the frontal surface of the yolk-sac
and lies almost perpendicular to the craniocaudal axis.
Although beginning to loop, the atrium and ventricle are still
laterally adjacent, with the atrium lying more ventrally and
slightly more caudally within the pericardial cavity. Over the
next 48 h, the volume of yolk diminishes as it is partially
absorbed, such that the heart begins to align along the
craniocaudal axis. The bulbus extends craniocaudally and
increases considerably in diameter. The heart continues to loop,with the atrium rotating towards the right and dorsally,
ultimately to adopt a position directly above the ventricle.
Importantly, DAF-2DA labeling of the bulbus is robust
throughout these morphological changes and continues beyond
a time at which the heart becomes essentially fully formed.
DAF-2DA is limited to tissues of the bulbus arteriosus and
does not mark any other region of the heart. We have therefore
discovered the first highly specific marker for the outflow
portion of the zebrafish heart and demonstrated its utility and
versatility in various experimental protocols conducted during
important developmental stages of this model species.
DAF-2DA is an unusual marker as it simply indicates the
presence of a small cell-signaling molecule, NO, within the
cytoplasm, rather than binding to a structural or functional
protein such as is the case for many other markers. Under
normal circumstances, NO is short lived within cells, but
reaction with the DAF-2DA-hydrolyzed product, DAF-2,
results in an accumulation of the fluorescent adduct, DAF-
2T. This effectively cages NO within the cytoplasm, and the
resulting fluorescence is thus indirectly indicative of the level
of NO production within the cell.
Since the identification of NO as an Fendothelial-derived
relaxation factor_ in the 1980s (Furchgott and Zawadski, 1980;
Ignarro et al., 1987), its multi-functional importance and almost
ubiquitous presence as a novel signaling molecule has become
evident. It has been implicated in the regulation of various
activities in organs, such as the brain, liver, kidneys, stomach
and heart, and in the ability of the immune system to mount an
effective response against viral, bacterial and parasitic infec-
tions and tumors. With specific regard to the cardiovascular
system, the vasodilatory effects of NO originally described by
Furchgott and Zawadski (1980) are now known to exert a
strong control on circulation and blood pressure by acting on
arterial and vascular smooth muscle cells. In addition, NO
protects the blood vessels by inhibiting vascular smooth muscle
proliferation and contraction and by preventing leukocyte
adhesion and the aggregation of platelets (Albrecht et al.,
2003; Gewaltig and Kojda, 2002). It has been shown that the
venous and arterial vasculature of zebrafish larvae is responsive
to endogenously produced NO (Fritsche et al., 2000), so the
fact that the zebrafish bulbus arteriosus produces high levels of
NO is intriguing. Further analysis of the phenomenon may lead
to a better understanding of the development, physiology and
function of this structure.
In other species, the requirement for NO in development is
well established. For example, Drosophila has a single nitric
oxide synthase gene (dNOS), known to be involved in the
development of the imaginal discs in the embryo and
responsible for the control of cell proliferation. A mutation in
dNOS that renders the enzyme inactive results in lethality at
late embryonic and larval stages (Regulski et al., 2004). In
contrast, there would appear to be some functional redundancy
between the three nitric oxide synthases found in mammals,
and although a triple loss-of-function phenotype has not been
established, mice in which two of these genes have been
ablated show drastically reduced viability (Huang et al., 1993,
1995). In the embryonic heart, certain developmental process-
A.C. Grimes et al. / Developmental Biology 290 (2006) 265–276 275es, including remodeling of the outflow tract, are directed by
cues such as hypoxia (Sugishita et al., 2004) and shear stress
forces (Groenendijk et al., 2004; Hove et al., 2003). As NO is
implicated in the vascular response to hypoxia (Ignarro et al.,
1987) and as the promoter for the endothelial nitric oxide
synthase gene (e-NOS) contains a sheer stress-responsive
element (Groenendijk et al., 2004), it seems intuitive that NO
is necessary for the normal cardiogenic program. Furthermore,
one could speculate that, as the teleost bulbus is particularly
hypoxic, lying at the very limit of the vasculature before blood
is oxygenated at the gills, this may account for the early and
strong response of NO release. Thus, as the gills are being
formed and the highly elastic bulbus is growing to prevent
back-flow and to protect the gills from fluctuations in blood
pressure, NO release likely induces dilatation of the vessel and
provides a means by which a uniform blood flow to the gills is
ensured.
Regardless of its nature in zebrafish, we have shown that
DAF-2DA is specifically localized to the bulbus, in addition to
a limited number of organs not associated with the cardiovas-
cular system. Importantly, it is not seen in any other region of
the heart during development and therefore allows the cells of
the bulbus to be visually segregated from those of the ventricle
and atrium. In addition, the fact that at later stages of
development, DAF-2DA reactivity colocalizes with known
markers of smooth muscle, such as anti-myosin light chain
kinase, suggests that it is an early marker of smooth muscle
phenotype. As further evidence of this, we have shown that
DAF-2DA also labels the arterial pole of the chick heart from
stages of development before smooth muscle markers are
effective but in regions that ultimately adopt a smooth muscle
phenotype. For example, DAF-2DA reactivity in Figs. 7H–I
and in Fig. 8 supports the observations of Waldo et al. (2005b),
who showed that, at day 11 of development (HH stage 37),
smooth muscle extends to the semilunar valves at the base of
the pulmonary trunk and aorta and is surrounded by the
myocardial wall. Importantly, while we cannot claim defini-
tively that DAF-2DA is marking smooth muscle in early
development, as we are unable to show its colocalization with
known markers in fish younger than 21 dpf, the fact that it
labels the bulbus from its earliest development through to
adulthood is clearly indicative that the bulbus is always
phenotypically distinct from the myocardium.
Intriguingly, the fact that DAF-2DA also marks the arterial
pole of the chick heart strongly suggests that this is a conserved
developmental or physiological phenomenon. More impor-
tantly, the region marked by DAF-2DA in chick is not
considered to be part of any heart chamber and is among the
tissues added to the heart from the secondary heart field. Could
this be the first tantalizing evidence for the presence of a
secondary heart field in the zebrafish? Whether or not this
proves to be the case, we are confident that we have provided
evidence that the zebrafish bulbus arteriosus has been wrongly
designated as a heart chamber and is actually more homologous
to the aortic trunk of higher vertebrates.
In conclusion, this work has effectively solved an enigma by
showing that a previously reported striated-to-smooth musclephenotypic change does not occur. Thus, the zebrafish may
after all be similar to other models of cardiogenesis and may be
well suited for the study of arterial pole development and
conotruncal malformations. A greater appreciation of this
hitherto neglected aspect of zebrafish cardiogenesis may help
to eliminate the confusion that pervades this area of research
and lead to a greater understanding about the development of
the arterial pole of the vertebrate heart.
Acknowledgments
We thank Dr. Mary Redmond Hutson for help with
imaging of sections. We are grateful to Dr. Debbie Yelon
and Heidi Auman at the New York University Medical Center
for sharing initial observations of DAF-2DA reactivity close
to the zebrafish heart. Thanks to the entire Kirby laboratory
group for invaluable support. This work was supported by
grants from NIH HL-36059, HL-70140, HD-39946, and a
Duke Environmental Health Science Research Center Grant to
M.L.K.
References
Albrecht, E.W., Stegemen, C.A., Heeringa, P., Henning, R.H., van Goor, H.,
2003. Protective role of endothelial nitric oxide synthase. J. Pathol. 199,
8–17.
Argue¨llo, C., Delacruz, M.V., Sanchez, C., 1978. Ultrastructural and
experimental evidence of myocardial cell differentiation into connec-
tive tissue cells in embryonic chick heart. J. Mol. Cell. Cardiol. 10,
307–315.
Bader, D., Masaki, T., Fischman, D.A., 1982. Immunochemical analysis of
myosin heavy chain during avian myogenesis in vivo and in vitro. J. Cell
Biol. 95, 763–770.
Bone, Q., Marshall, N.B., Blaxter, J.H.S., 1999. Biology of Fishes. Stanley
Thornes, Cheltenham, UK.
Epstein, F.H., Epstein, J.A., 2005. A perspective on the value of aquatic models
in biomedical research. Exp. Biol. Med. 230, 1–7.
Farrell, A.P., Jones, D.R., 1992. The heart. In: Hoar, W.S., Randall, D.J.,
Farrell, A.P. (Eds.), Fish Physiology, The Cardiovascular System, Part A,
vol. XII. Academic Press, San Diego, pp. 1–87.
Fishman, M.C., Chien, K.R., 1997. Fashioning the vertebrate heart: earliest
embryonic decisions. Development 124, 2099–2117.
Fritsche, R., Schwerte, T., Pelster, B., 2000. Nitric oxide and vascular reactivity
in developing zebrafish, Danio rerio. Am. J. Physiol.: Regul., Integr.
Comp. Physiol. 279, R2200–R2207.
Furchgott, R.F., Zawadski, J.F., 1980. The obligatory role of endothelial cells
in the relaxation of arterial smooth muscle by acetylcholine. Nature 288,
373–376.
Gewaltig, M.T., Kojda, G., 2002. Vasoprotection by nitric oxide: mechanisms
and therapeutic potentials. Cardiovasc. Res. 55, 250–260.
Goodrich, E.S., 1930. Studies on the Structure and Development of Vertebrates.
Macmillan, London.
Groenendijk, B.C.W., Hierck, B.P., Gittenberger-de Groot, A.C., Poelmann,
R.E., 2004. Development-related changes in the expression of shear stress
responsive genes KLF-2, ET-1, and NOS-3 in the developing cardiovascular
system of chicken embryos. Dev. Dyn. 230, 57–68.
Guerrero, A., Icardo, J.M., Duran, A.C., Gellego, A., Domezain, A., Colvee,
E., Sans-Coma, V., 2004. Differentiation of the cardiac outflow tract
components in alevins of the sturgeon Acipenser naccarii (Osteichthyes,
Acipenseriformes): implications for heart evolution. J. Morphol. 260,
172–183.
Hamburger, V., Hamilton, H.L., 1951. A series of normal stages in the
development of the chick embryo. J. Morphol. 88, 49–92.
A.C. Grimes et al. / Developmental Biology 290 (2006) 265–276276Hickman, C.P., Roberts, L.S., Hickman, F.M., 1988. Integrated Principles of
Zoology. Times Mirror/Mosby College Publishing, St. Louis.
Hove, J.R., Koster, R.W., Forouhar, A.S., Acevedo-bolton, G., Fraser, S.E.,
Gharib, M., 2003. Intracardiac fluid forces are an essential epigenetic factor
for embryonic cardiogenesis. Nature 421, 172–177.
Hu, N., Sedmera, D., Yost, J., Clark, E.B., 2000. Structure and function of the
developing zebrafish heart. Anat. Rec. 260, 148–157.
Hu, N., Yost, H.J., Clark, E.B., 2001. Cardiac morphology and blood pressure
in the adult zebrafish. Anat. Rec. 264, 1–12.
Huang, P.L., Dawson, T.M., Bredt, D.S., Snyder, S.H., Fishman, M.C., 1993.
Targeted disruption of the neuronal nitric oxide synthase gene. Cell 75,
1273–1286.
Huang, P.L., Huang, Z., Mashimo, H., Bloch, K.D., Moskowitz, M.A., Bevan,
J.A., Fishman, M.C., 1995. Hypertension in mice lacking the gene for
endothelial nitric oxide synthase. Nature 377, 239–242.
Ignarro, L.J., Buga, G.M., Wood, K.S., Byrns, R.E., Chadhuri, G., 1987.
Endothelium-derived relaxing factor produced and released from artery and
vein is nitric oxide. Proc. Natl. Acad. Sci. U. S. A. 84, 9265–9269.
Keegan, B.R., Meyer, D., Yelon, D., 2004. Organization of cardiac chamber
progenitors in the zebrafish blastula. Development 131, 3081–3091.
Kimmel, C.B., Ballard, W.B., Kimmel, S.R., Ullman, B., Schilling, T.F.,
1995. Stages of embryonic development of the zebrafish. Dev. Dyn. 203,
253–310.
Kojima, H., Nakatsubo, N., Kikuchi, K., Kawahara, S., Kirino, Y., Nagoshi,
H., Hirata, Y., Nagano, T., 1998. Detection and imaging of nitric oxide
with novel fluorescent indicators: diaminofluoresceins. Anal. Chem. 70,
2446–2453.
Lawson, R., 1979. The comparative anatomy of the circulatory system. In:
Wake, M.H. (Ed.), Hyman’s Comparative Vertebrate Anatomy, 3rd edR
University of Chicago Press, Chicago, pp. 448–554.
Mably, J.D., Mohideen, M.A.P.K., Burns, C.G., Chen, J.N., Fishman, M.C.,
2003. Heart of glass regulates the concentric growth of the heart in
zebrafish. Curr. Biol. 13, 2138–2147.
McCauley, W.J., 1971. Vertebrate Physiology. W.B. Saunders Company,
Philadelphia.
Nusslein-Volhard, C., Dahm, R. (Eds.), 2002. Zebrafish. Practical Approach.
Oxford Univ. Press, Oxford.
Orr, R.T., 1982. Vertebrate Biology, 5th edR Saunders College Publishing.Regulski, M., Stasiv, Y., Tully, T., Enikolopov, G., 2004. Essential function of
nitric oxide synthase in Drosophila. Curr. Biol. 14, 881–882.
Rothenberg, F., Fisher, S.A., Watanabe, M., 2003. Sculpting the cardiac outflow
tract. Birth Defects Res., Part C 69, 38–45.
Satchell, G.H., 1991. Physiology and Form of Fish Circulation. Cambridge
Univ. Press, Cambridge.
Schib, J.L., Icardo, J.M., Duran, A.C., Guerrero, A., Lopez, D., de Andres,
A.V., Sans-Coma, V., 2002. The conus arteriosus of the adult gilthead
seabream (Sparus auratus). J. Anat. 201, 395–404.
Schmidt-Nielsen, K., 1997. Animal Physiology, 5th edR Cambridge Univ. Press,
Cambridge.
Simo˜es, K., Vicentini, C.A., Orsi1, A.M., Cruz, C., 2002. Myoarchitecture and
vasculature of the heart ventricle in some freshwater teleosts. J. Anat. 200,
467–475.
Stainier, D.Y.R., Lee, R.K., Fishman, M.C., 1993. Cardiovascular development
in the zebrafish: I. Myocardial fate map and heart tube formation.
Development 119, 31–40.
Sugishita, Y., Watanabe, M., Fisher, S., 2004. Role of myocardial hypoxia in
the remodeling of the embryonic avian cardiac outflow tract. Dev. Biol.
267, 294–308.
Waldo, K.L., Hutson, M.R., Stadt, H.A., Zdanowicz, M., Zdanowicz, J., Kirby,
M.L., 2005a. Cardiac neural crest is necessary for normal addition of the
myocardium to the arterial pole from the secondary heart field. Dev. Biol.
281, 66–77.
Waldo, K., Hutson, M.R., Ward, C.C., Zdanowicz, M., Stadt, H.A., Kumiski,
D., Abu-Issa, R., Stadt, H.A., Kirby, M.L., 2005b. Secondary heart field
contributes myocardium and smooth muscle to the arterial pole of the
developing heart. Dev. Biol. 281, 78–90.
Watanabe, M., Choudry, A., Berlan, M., Singal, A., Siwik, E., Mohr, S., Fisher,
S.A., 1998. Developmental remodeling and shortening of the cardiac
outflow tract involves myocyte programmed cell death. Development 125,
3809–3820.
Westerfield, M., 1993. The Zebrafish Book. University of Oregon Press,
Eugene, OR.
Ya, J., van den Hoff, M.J.B., de Boer, P.A.J., Tesink-Taekema, S., Franco, D.,
Moorman, A.F.M., Lamers, W.H., 1998. The normal development of the
outflow tract in the rat. Circ. Res. 82, 464–472.
Young, J.Z., 1981. The Life of Vertebrates, 3rd edR Clarendon Press, Oxford.
